Andrew Powell
aclaris, autem
director
In 25 years as an executive leader in the biotech industry, Andrew has participated in generating more than $25 billion in shareholder value through a series of successful transactions. He has worked with fast-growing companies through transformative stages in their development, ultimately helping to create, and then execute, three of the largest biotech deals of the decade: the sale of Medivation to Pfizer; the sale of InterMune to Roche; and the sale of ImClone Systems to Lilly.
Trained as a lawyer, he has been able to organize and motivate diverse teams to see the strategic intersection between risk management (dull) and value creation (exciting). He played a key role developing ImClone, InterMune and Medivation into rigorous commercial organizations that were both compliant and equipped for growth in the U.S. and beyond. Similarly, at CollaGenex and Cornerstone, he helped dynamic leadership navigate change and reinvent IP and regulatory strategies to multiply shareholder value.
At the start of his career, Andrew spent several years with Baxter International, working on the ground to expand business in multiple countries and establishing more than a dozen joint ventures in developing economies. He has continued his efforts to expand access to healthcare by serving as an advisor to the WIN and Red Segura nonprofit healthcare initiatives in Senegal and Honduras and by working with the Hypersomnia Foundation to engage drug companies in developing treatments for this rare neurological disorder.
He serves on the boards of Aclaris, Inc., a NASDAQ-listed biotechnology company; Cure Network Ventures, the enterprise arm of the Gladstone Institutes at the University of California; and NeuDrive Limited, a U.K. company developing technology to disrupt drug development and diagnostics. He also advises a number of young companies and is a member of the Band of Angels, an angel investor group focused on funding and mentoring technology driven startups in the San Francisco Bay Area.
Andrew attended Winchester College in England, is a Morehead Scholar from the University of North Carolina at Chapel Hill, and earned a J.D. at Stanford.
Learn more about Andrew: https://www.linkedin.com/in/akwpowell/